Narjis Boukli

428 total citations
13 papers, 203 citations indexed

About

Narjis Boukli is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Narjis Boukli has authored 13 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Narjis Boukli's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Narjis Boukli is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Narjis Boukli collaborates with scholars based in France, Cambodia and Madagascar. Narjis Boukli's co-authors include Christine Katlama, Joël Gozlan, Catherine Leport, Dominique Costagliola, Anne‐Marie Fillet, Sophie Matheron, Éric Caumes, Jacques Gasnault, Dominique Salmon and Rémi Lancar and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the Rheumatic Diseases and AIDS.

In The Last Decade

Narjis Boukli

13 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Narjis Boukli France 8 142 94 71 15 13 13 203
Stephen Kegg United Kingdom 4 173 1.2× 66 0.7× 51 0.7× 9 0.6× 34 2.6× 11 236
B. Chanzy France 9 147 1.0× 201 2.1× 107 1.5× 37 2.5× 8 0.6× 21 307
Yvonne J. Bryson United States 5 203 1.4× 51 0.5× 29 0.4× 15 1.0× 41 3.2× 5 246
Claudia Michalik Germany 8 86 0.6× 57 0.6× 51 0.7× 26 1.7× 4 0.3× 16 151
C. Tural Spain 8 285 2.0× 158 1.7× 155 2.2× 14 0.9× 11 0.8× 10 376
John Diaz‐Decaro United States 8 296 2.1× 76 0.8× 19 0.3× 16 1.1× 69 5.3× 20 353
James Homans United States 10 342 2.4× 222 2.4× 37 0.5× 12 0.8× 39 3.0× 18 448
G. Pialoux France 9 103 0.7× 132 1.4× 76 1.1× 24 1.6× 14 1.1× 33 250
Jan Gerstoft Denmark 4 73 0.5× 194 2.1× 143 2.0× 5 0.3× 9 0.7× 4 231
Julia Jensen Spain 6 90 0.6× 99 1.1× 8 0.1× 14 0.9× 12 0.9× 11 134

Countries citing papers authored by Narjis Boukli

Since Specialization
Citations

This map shows the geographic impact of Narjis Boukli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjis Boukli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjis Boukli more than expected).

Fields of papers citing papers by Narjis Boukli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narjis Boukli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjis Boukli. The network helps show where Narjis Boukli may publish in the future.

Co-authorship network of co-authors of Narjis Boukli

This figure shows the co-authorship network connecting the top 25 collaborators of Narjis Boukli. A scholar is included among the top collaborators of Narjis Boukli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narjis Boukli. Narjis Boukli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Boukli, Narjis, Claude Flamand, Jelena D. Milosevic Feenstra, et al.. (2023). One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance. Frontiers in Medicine. 10. 1161268–1161268. 9 indexed citations
2.
Schnuriger, Aurélie, Marine Perrier, Yanne Michel, et al.. (2021). Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value. Diagnostic Microbiology and Infectious Disease. 100(3). 115366–115366. 8 indexed citations
3.
Raberahona, Mihaja, Mamy Jean de Dieu Randria, Dolorès Pourette, et al.. (2020). Is Madagascar at the edge of a generalised HIV epidemic? Situational analysis. Sexually Transmitted Infections. 97(1). 27–32. 8 indexed citations
4.
Boukli, Narjis, et al.. (2019). Intérêt et limites de l’utilisation des TROD Multiplex VIH/syphilis en CeGIDD. Médecine et Maladies Infectieuses. 49(4). S93–S93. 1 indexed citations
5.
Boukli, Narjis, et al.. (2018). Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads. Journal of Antimicrobial Chemotherapy. 73(11). 3129–3136. 12 indexed citations
6.
Boukli, Narjis, et al.. (2017). Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection. Sexually Transmitted Infections. 94(7). 475–478. 3 indexed citations
7.
Soulié, Cathia, Djeneba Fofana, Narjis Boukli, et al.. (2016). Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype. Journal of Clinical Virology. 76. 51–54. 3 indexed citations
8.
Launay, Odile, Laurent Roudière, Narjis Boukli, et al.. (2004). Assessment of Cetirizine, an Antihistamine, to Prevent Cutaneous Reactions to Nevirapine Therapy: Results of the Viramune‐Zyrtec Double‐Blind, Placebo‐Controlled Trial. Clinical Infectious Diseases. 38(8). e66–e72. 18 indexed citations
9.
Meynard, J.‐L., Michel Guiguet, A. Rachline, et al.. (2001). Facteurs prédictifs de réponse virologique à un traitement antirétroviral avec inhibiteur de protéase au cours de l'infection à VIH. La Presse Médicale. 30(1). 5–10. 1 indexed citations
10.
Guiguet, Marguerite, A. Rachline, Narjis Boukli, et al.. (2001). [Predictive factors of virologic response to antiretroviral treatment with a protease inhibitor in HIV infection].. PubMed. 30(1). 5–10. 3 indexed citations
11.
Salmon‐Céron, Dominique, Marie‐Christine Mazeron, Narjis Boukli, et al.. (2000). Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy. AIDS. 14(8). 1041–1049. 57 indexed citations
12.
Fillet, Anne‐Marie, Joël Gozlan, Rémi Lancar, et al.. (2000). Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 14(5). 517–524. 69 indexed citations
13.
Cacoub, P., Narjis Boukli, Pierre Hausfater, et al.. (1998). Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia. Annals of the Rheumatic Diseases. 57(7). 422–424. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Kegg Breakdown of academic impact, for papers by B. Chanzy Breakdown of academic impact, for papers by Yvonne J. Bryson Breakdown of academic impact, for papers by Claudia Michalik Breakdown of academic impact, for papers by C. Tural Breakdown of academic impact, for papers by John Diaz‐Decaro Breakdown of academic impact, for papers by James Homans Breakdown of academic impact, for papers by G. Pialoux Breakdown of academic impact, for papers by Jan Gerstoft Breakdown of academic impact, for papers by Julia Jensen
Rankless by CCL
2026